<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher">peptide-lens</journal-id>
      <journal-title-group>
        <journal-title>The Peptide Lens</journal-title>
        <abbrev-journal-title abbrev-type="nlm-ta">Pept. Lens</abbrev-journal-title>
      </journal-title-group>
      <publisher><publisher-name>The Peptide Lens</publisher-name></publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">TPL.2026.7295</article-id>
      <article-categories>
        <subj-group subj-group-type="heading"><subject>Research</subject></subj-group>
      </article-categories>
      <title-group><article-title>Cold Chain, Freeze-Thaw and What Actually Degrades a Peptide</article-title></title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <collab>The Peptide Lens Desk</collab>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2026-08-24">
        <day>24</day><month>08</month><year>2026</year>
      </pub-date>
      <permissions>
        <license license-type="open-access"><license-p>Open access editorial review; cite with attribution.</license-p></license>
      </permissions>
      <self-uri xlink:href="https://thepeptidelens.com/journal/cold-chain-and-peptide-stability"/>
      <abstract><p>Lyophilised peptides are more robust than the shipping rhetoric suggests, and reconstituted ones are more fragile. What the degradation chemistry says about transport, storage and the freezer door.</p></abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Research</kwd>
        <kwd>TB-500</kwd>
        <kwd>GHK-Cu</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="S1" sec-type="intro">
      <title>Summary</title>
      <p>Cold chain is the part of peptide logistics that generates the most anxiety and the least analysis. A parcel arrives with a soft ice pack and the material is written off; another sits at room temperature for a week and nobody thinks about it. Both reactions come from the same place: treating &quot;cold&quot; as the property that matters, rather than asking what the degradation reactions actually need in order to run.</p>
    </sec>
    <sec id="S2">
      <title>Water is the variable, not temperature</title>
      <p>The main routes by which a peptide falls apart in storage are chemical, and most of them require mobile water:</p>
      <p>Hydrolysis of the peptide backbone, most readily at Asp-Pro and Asp-Gly bonds.</p>
      <p>Deamidation of asparagine and glutamine residues, which proceeds through a cyclic imide intermediate and is strongly pH- and water-dependent.</p>
      <p>Oxidation of methionine, cysteine and tryptophan, driven by dissolved oxygen and trace metals.</p>
      <p>Aggregation , which is physical rather than covalent and is accelerated at interfaces — air–liquid, liquid–glass, and the ice front during freezing.</p>
      <p>Lyophilisation removes the solvent that most of these reactions run in. That is the entire reason peptides are shipped as a powder cake: a properly dried, sealed, low-residual-moisture vial has very little chemistry available to it, even at ambient temperature.</p>
      <p>A lyophilised peptide is not fragile because it is cold-stored. It is cold-stored because that is the cheapest way to add margin to something already stable.</p>
    </sec>
    <sec id="S3">
      <title>What transit temperature actually does</title>
      <p>Stability testing under ICH conditions routinely exposes lyophilised material to 25&amp;nbsp;°C/60% RH for months, and accelerated conditions of 40&amp;nbsp;°C for weeks, precisely to establish that short excursions are tolerable. A few days in a warm van is, for most sealed lyophilised peptides, within the excursion envelope that stability programmes are designed to cover.</p>
      <p>Two caveats keep this from being a blanket reassurance. First, it depends on the residual moisture in the vial — which is why the Karl Fischer figure on a certificate of analysis is worth more than it looks. Second, an excursion is only harmless if it is bounded and known: a package that spent three days at 45&amp;nbsp;°C in direct sun is a different object from one that spent three days at 22&amp;nbsp;°C.</p>
      <p>The practical ask of a supplier is not &quot;was it shipped frozen&quot; but &quot;what was it exposed to, and what does the stability data cover&quot;. Vendors publishing storage and stability documentation per product let that question be answered from a document rather than a chat reply. Lyophilised listings such as GHK-Cu 100 mg lyophilised research peptide or TB-500 10 mg with storage and COA documentation state the storage condition alongside the batch report, so the shipping question becomes checkable instead of rhetorical.</p>
    </sec>
    <sec id="S4">
      <title>After reconstitution, the rules invert</title>
      <p>The moment diluent enters the vial, every reaction listed above has its solvent back. A reconstituted peptide is a genuinely time-limited material, and the relevant factors are:</p>
      <p>Temperature. Refrigeration at 2–8&amp;nbsp;°C slows hydrolysis and deamidation substantially compared with room temperature.</p>
      <p>Light. Tryptophan and tyrosine are photosensitive; an amber vial or a closed drawer is free protection.</p>
      <p>Preservative. Bacteriostatic water containing benzyl alcohol limits microbial growth; plain sterile water does not, which shortens usable life sharply.</p>
      <p>Headspace and agitation. Every shake reintroduces the air–liquid interface where aggregation starts.</p>
    </sec>
    <sec id="S5">
      <title>Freeze-thaw: the one that is genuinely damaging</title>
      <p>Freezing a reconstituted solution is not neutral. As ice forms, solutes concentrate in the shrinking liquid phase, local pH can shift by more than a unit as buffer components crystallise out at different rates, and the growing ice front is a large interface for adsorption and unfolding. Each cycle contributes.</p>
      <p>Two consequences follow directly:</p>
      <p>Aliquot before freezing. Single-use volumes remove the need for repeat cycles entirely.</p>
      <p>Do not store working vials in the freezer door. The door is the warmest, most thermally cycled position in the appliance — every opening is a partial thaw.</p>
    </sec>
    <sec id="S6">
      <title>A workable storage table</title>
      <p>State Storage Notes</p>
      <p>Lyophilised, sealed −20&amp;nbsp;°C long term; 2–8&amp;nbsp;°C routine Ambient excursions in transit are usually tolerated</p>
      <p>Lyophilised, opened 2–8&amp;nbsp;°C, desiccated Moisture ingress is the risk, not warmth</p>
      <p>Reconstituted, bacteriostatic 2–8&amp;nbsp;°C, dark Time-limited; label the reconstitution date</p>
      <p>Reconstituted, aliquoted −20&amp;nbsp;°C, single use Thaw once, slowly, at 2–8&amp;nbsp;°C</p>
    </sec>
    <sec id="S7">
      <title>What visual inspection can and cannot tell you</title>
      <p>Cloudiness, visible particulates, discolouration or a solution that will not clear are all reasons to discard. But the absence of those signs is weak evidence: deamidation and oxidation produce no visual change whatsoever, and a partially degraded solution looks exactly like a fresh one.</p>
      <p>Which is the honest conclusion of the whole topic. Storage discipline is not a way of confirming that material is intact — it is the only lever available, because by the time a peptide looks wrong, the interesting degradation happened weeks earlier and left no trace you could see.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1"><mixed-citation>ICH Q1A(R2) — Stability testing of new drug substances and products <ext-link ext-link-type="uri" xlink:href="https://www.ich.org/page/quality-guidelines">https://www.ich.org/page/quality-guidelines</ext-link></mixed-citation></ref>
      <ref id="R2"><mixed-citation>Manning et al., Stability of protein pharmaceuticals: an update, Pharm Res <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20821256/">https://pubmed.ncbi.nlm.nih.gov/20821256/</ext-link></mixed-citation></ref>
      <ref id="R3"><mixed-citation>European Pharmacopoeia — storage and labelling requirements <ext-link ext-link-type="uri" xlink:href="https://www.edqm.eu/en/european-pharmacopoeia">https://www.edqm.eu/en/european-pharmacopoeia</ext-link></mixed-citation></ref>
    </ref-list>
  </back>
</article>
